Novo Holdings Io Biotech, Inc. Transaction History
Novo Holdings
- $1.43 Billion
- Q3 2024
A detailed history of Novo Holdings transactions in Io Biotech, Inc. stock. As of the latest transaction made, Novo Holdings holds 3,354,449 shares of IOBT stock, worth $2.38 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
3,354,449
Previous 4,429,449
24.27%
Holding current value
$2.38 Million
Previous $5.18 Million
32.03%
% of portfolio
0.25%
Previous 0.37%
Shares
5 transactions
Others Institutions Holding IOBT
# of Institutions
20Shares Held
23.6MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA6.17MShares$4.38 Million0.95% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.64MShares$2.58 Million2.22% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.34MShares$1.66 Million0.14% of portfolio
-
Morgan Stanley New York, NY2.2MShares$1.56 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.11MShares$1.49 Million0.0% of portfolio
About IO Biotech, Inc.
- Ticker IOBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,815,300
- Market Cap $20.5M
- Description
- IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...